WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Seahorse Bioscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 26, 2008, 28(13):3521-3530; doi:10.1523/JNEUROSCI.0204-08.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Origlia, N.
Right arrow Articles by Domenici, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Origlia, N.
Right arrow Articles by Domenici, L.

 Previous Article

Development/Plasticity/Repair
Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

Nicola Origlia,1 Massimo Righi,2 Simona Capsoni,3 Antonino Cattaneo,4 Fang Fang,5 David M. Stern,7 John Xi Chen,8 Ann Marie Schmidt,5 Ottavio Arancio,6 Shi Du Yan,5,6 and Luciano Domenici1,9

1Institute of Neuroscience (CNR), Pisa 56100, Italy, 2International School for Advanced Studies (SISSA), Trieste 34014, Italy, 3Lay Line Genomics, Rome 00128, Italy, 4European Brain Research Institute, Rome 00143, Italy, 5Department of Surgery and 6Department of Pathology and Taub Institute, Columbia University, New York, New York 10032, 7Dean's Office, University of Cincinnati, Cincinnati, Ohio 45267, 8Harvey Cushing Institutes of Neuroscience, North Shore-Long Island Jewish Health System, New York, New York 11021, and 9Department STB, University of L'Aquila, L'Aquila 67010, Italy

Correspondence should be addressed to either of the following: Luciano Domenici, Institute of Neuroscience (CNR), Via G. Moruzzi 1, 56100, Pisa, Italy, Email: domenici{at}in.cnr.it; or Shi Du Yan, Department of Pathology and Surgery, Taub Institute Columbia University, New York, NY 10032, Email: sdy1{at}columbia.edu

Soluble amyloid-β (Aβ) peptide is likely to play a key role during early stages of Alzheimer's disease (AD) by perturbing synaptic function and cognitive processes. Receptor for advanced glycation end products (RAGE) has been identified as a receptor involved in Aβ-induced neuronal dysfunction. We investigated the role of neuronal RAGE in Aβ-induced synaptic dysfunction in the entorhinal cortex, an area of the brain important in memory processes that is affected early in AD. We found that soluble oligomeric Aβ peptide (Aβ42) blocked long-term potentiation (LTP), but did not affect long-term depression, paired-pulse facilitation, or basal synaptic transmission. In contrast, Aβ did not inhibit LTP in slices from RAGE-null mutant mice or in slices from wild-type mice treated with anti-RAGE IgG. Similarly, transgenic mice expressing a dominant-negative form of RAGE targeted to neurons showed normal LTP in the presence of Aβ, suggesting that neuronal RAGE functions as a signal transducer for Aβ-mediated LTP impairment. To investigate intracellular pathway transducing RAGE activation by Aβ, we used inhibitors of stress activated kinases. We found that inhibiting p38 mitogen-activated protein kinase (p38 MAPK), but not blocking c-Jun N-terminal kinase activation, was capable of maintaining LTP in Aβ-treated slices. Moreover, Aβ-mediated enhancement of p38 MAPK phosphorylation in cortical neurons was reduced by blocking antibodies to RAGE. Together, our results indicate that Aβ impairs LTP in the entorhinal cortex through neuronal RAGE-mediated activation of p38 MAPK.

Key words: amyloid-β; protein; LTP; RAGE; p38 MAPK; entorhinal cortex; Alzheimer's disease


Received June 15, 2007; revised Feb. 19, 2008; accepted Feb. 22, 2008.

Correspondence should be addressed to either of the following: Luciano Domenici, Institute of Neuroscience (CNR), Via G. Moruzzi 1, 56100, Pisa, Italy, Email: domenici{at}in.cnr.it; or Shi Du Yan, Department of Pathology and Surgery, Taub Institute Columbia University, New York, NY 10032, Email: sdy1{at}columbia.edu




This article has been cited by other articles:


Home page
BrainHome page
N.-W. Hu, I. M. Smith, D. M. Walsh, and M. J. Rowan
Soluble amyloid-{beta} peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo
Brain, September 1, 2008; 131(9): 2414 - 2424.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-